Trends in HPV Vaccination Before Age 13 Years in the US National Immunization Survey-Teen

Jodie L White; M Kate Grabowski; Thomas C Quinn; Aaron A R Tobian; Eshan U Patel

doi:10.1001/jamapediatrics.2023.5238

Trends in HPV Vaccination Before Age 13 Years in the US National Immunization Survey-Teen

JAMA Pediatr. 2024 Feb 1;178(2):203-205. doi: 10.1001/jamapediatrics.2023.5238.

Authors

Jodie L White¹, M Kate Grabowski¹, Thomas C Quinn², Aaron A R Tobian¹, Eshan U Patel³

Affiliations

¹ Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
² Division of Intramural Research, National Institute of Allergy and Infectious Diseases, Baltimore, Maryland.
³ Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

PMID: 38109082
PMCID: PMC10728796 (available on 2024-12-18)
DOI: 10.1001/jamapediatrics.2023.5238

No abstract available

Plain language summary

This survey study uses data from the National Immunization Survey–Teen to examine human papillomavirus (HPV) vaccination rates in adolescents aged 13 to 17 years, including rates of series completion before age 13 years.

MeSH terms

Adolescent
Humans
Immunization
Papillomavirus Infections* / epidemiology
Papillomavirus Infections* / prevention & control
Papillomavirus Vaccines*
United States
Vaccination

Substances

Papillomavirus Vaccines